Search Results - Tzortzini, Eva

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2

    Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2 by Toft-Bertelsen, Trine Lisberg, Jeppesen, Mads Gravers, Tzortzini, Eva, Xue, Kai, Giller, Karin, Becker, Stefan, Mujezinovic, Amer, Bentzen, Bo Hjorth, B Andreas, Loren, Kolocouris, Antonios, Kledal, Thomas Nitschke, Rosenkilde, Mette Marie

    Published in Communications biology
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro

    Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro by Toft-Bertelsen, Trine Lisberg, Jeppesen, Mads Gravers, Tzortzini, Eva, Xue, Kai, Giller, Karin, Becker, Stefan, Mujezinovic, Amer, Bentzen, Bo Hjorth, Andreas, Loren B., Kolocouris, Antonios, Kledal, Thomas Nitschke, Rosenkilde, Mette Marie

    Published in Communications biology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Insights to the Binding of a Selective Adenosine A3 Receptor Antagonist Using Molecular Dynamic Simulations, MM-PBSA and MM-GBSA Free Energy Calculations, and Mutagenesis

    Insights to the Binding of a Selective Adenosine A3 Receptor Antagonist Using Molecular Dynamic Simulations, MM-PBSA and MM-GBSA Free Energy Calculations, and Mutagenesis by Lagarias, Panagiotis, Barkan, Kerry, Tzortzini, Eva, Stampelou, Margarita, Vrontaki, Eleni, Ladds, Graham, Kolocouris, Antonios

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Correction to Insights to the Binding of a Selective Adenosine A3 Receptor Antagonist using Molecular Dynamic Simulations, MM-PBSA and MM-GBSA Free Energy Calculations, and Mutagenesis

    Correction to Insights to the Binding of a Selective Adenosine A3 Receptor Antagonist using Molecular Dynamic Simulations, MM-PBSA and MM-GBSA Free Energy Calculations, and Mutagen... by Lagarias, Panagiotis, Barkan, Kerry, Tzortzini, Eva, Stampelou, Margarita, Vrontaki, Eleni, Ladds, Graham, Kolocouris, Antonios

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Correction to Insights to the Binding of a Selective Adenosine A 3 Receptor Antagonist using Molecular Dynamic Simulations, MM-PBSA and MM-GBSA Free Energy Calculations, and Mutagenesis

    Correction to Insights to the Binding of a Selective Adenosine A 3 Receptor Antagonist using Molecular Dynamic Simulations, MM-PBSA and MM-GBSA Free Energy Calculations, and Mutage... by Lagarias, Panagiotis, Barkan, Kerry, Tzortzini, Eva, Stampelou, Margarita, Vrontaki, Eleni, Ladds, Graham, Kolocouris, Antonios

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  6. 6
    Insights to the Binding of a Selective Adenosine A 3 Receptor Antagonist Using Molecular Dynamic Simulations, MM-PBSA and MM-GBSA Free Energy Calculations, and Mutagenesis

    Insights to the Binding of a Selective Adenosine A 3 Receptor Antagonist Using Molecular Dynamic Simulations, MM-PBSA and MM-GBSA Free Energy Calculations, and Mutagenesis by Lagarias, Panagiotis, Barkan, Kerry, Tzortzini, Eva, Stampelou, Margarita, Vrontaki, Eleni, Ladds, Graham, Kolocouris, Antonios

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro

    Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro by Toft-Bertelsen, Trine Lisberg, Jeppesen, Mads Gravers, Tzortzini, Eva, Xue, Kai, Giller, Karin, Becker, Stefan, Mujezinovic, Amer, Bentzen, Bo Hjorth, B. Andreas, Loren, Kolocouris, Antonios, Kledal, Thomas Nitschke, Rosenkilde, Mette Marie

    Published in Communications biology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms

    One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms by Rank, Andreas, Tzortzini, Athanasia, Kling, Elisabeth, Schmid, Christoph, Claus, Rainer, Löll, Eva, Burger, Roswitha, Römmele, Christoph, Dhillon, Christine, Müller, Katharina, Girl, Philipp, Hoffmann, Reinhard, Grützner, Stefanie, Dennehy, Kevin M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: